TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/24 16:10 | 5/23/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | D | S | -32 | 14.93 | 0 | -2 | -10 | 19 | D | |||||||||||||||
4/2/24 16:25 | 4/1/24 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | D | S | -16 | 13.07 | 0 | -1 | -5 | 21 | D | |||||||||||||||
5/24/23 17:15 | 5/23/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | D | S | -27 | 1.04 | 0 | -26 | -13 | 169 | D | |||||||||||||||
3/31/23 16:45 | 3/30/23 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | D | S | -12 | 0.8232 | 0 | -15 | -8 | 178 | D | |||||||||||||||
8/10/22 17:00 | 8/8/22 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | DO | CEO | S | -26 | 2.13 | 0 | -12 | -6 | 193 | D | ||||||||||||||
3/31/22 16:36 | 3/30/22 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McHutchison John G | CA | DO | CEO,P | S.d | -10 | 2.17 | 0 | -5 | -2 | 205 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |